GlassScriptPhysician profile
Joseph R Pendley
NPI 1902250137
$8,133.88
in general payments reported to CMS, 2019-2025
40 companies · $1,652 in 2025
The $1,652 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $1,192 · 2023: $2,357 · 2024: $2,684 · 2025: $1,652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,661 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,660.74 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $821.13 | 2021-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $564.91 | 2023-2025 | |
| Abiomed | $545.73 | 2023-2025 | Impella |
| Pfizer INC. | $483.15 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $440.74 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.48 | 2021-2025 | Jardiance |
| Medtronic, INC. | $414.48 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Cobalt Dr Mri Surescan |
| Amgen INC. | $400.08 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $381.12 | 2022-2025 | Lifevest |
| Abbott Laboratories | $307.22 | 2022-2025 | Ensite Precision, Mitraclip, Aveir |
| Atricure, INC. | $268.10 | 2022-2023 | |
| Lantheus Medical Imaging, INC. | $253.65 | 2021-2025 | |
| Scpharmaceuticals INC. | $250.38 | 2023-2025 | |
| Novo Nordisk INC | $224.48 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Alnylam Pharmaceuticals INC. | $204.04 | 2023-2025 | Amvuttra |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $181.28 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $179.73 | 2022-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $162.93 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $147.08 | 2023-2025 | Opsumit, Uptravi |
| Philips North America LLC | $138.24 | 2023-2025 | (Ck4) Mcot, Ecc Solutions |
| Shockwave Medical, INC | $129.54 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $117.83 | 2021-2025 | Wainua, Farxiga, Brilinta |
| Regeneron Healthcare Solutions, INC. | $116.44 | 2022-2025 | Evkeeza, Praluent |
| Edwards Lifesciences Corporation | $103.33 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Angiodynamics, INC. | $100.00 | 2024 | Alphavac |
| Kestra Medical Technology Services, INC. | $99.44 | 2025 | Assure Wcd |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Merck Sharp & Dohme LLC | $91.05 | 2022-2024 | Verquvo |
| Heartflow, INC. | $85.63 | 2025 | |
| Azurity Pharmaceuticals, INC. | $75.59 | 2023-2024 | Edarbyclor, Edarbi |
| Daiichi Sankyo INC. | $73.80 | 2023-2024 | Injectafer |
| Sanofi-Aventis U.S. LLC | $67.91 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $32.24 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $31.60 | 2025 | |
| Inari Medical, INC. | $27.66 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Catheter Precision INC. | $24.14 | 2024 | |
| Stryker Corporation | $22.48 | 2025 | Flowtriever |
| Teleflex LLC | $22.13 | 2022 | |
| Amarin Pharma, INC. | $15.72 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.